Xcout Intel
Xaira Therapeutics
Xaira Therapeutics is an integrated biotechnology company headquartered in the San Francisco Bay Area in California. The company focuses on leveraging advanced scientific methods for therapeutic discovery and development.
Subscribe to see Xaira Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Xaira Therapeutics at a glance
Xaira Therapeutics is a biotech company headquartered in United States. Its most recent funding round, Series B, raised $1B in April 2024. Xcout tracks 18 named people at Xaira Therapeutics, including Marc Tessier-Lavigne (Chairman & Chief Executive Officer). Xcout recorded 36 job postings from Xaira Therapeutics in the last 90 days, naming tools such as PyTorch, NetSuite, Model Context Protocol.
Xaira Therapeutics leadership
- Marc Tessier-LavigneChairman & Chief Executive Officer
- Hetu KamichettyChief Technology Officer
- Bo WangChief AI Scientist
- Ci ChuChief Discovery Officer
- Debbie LawChief Scientific Officer
- Julia TranChief People Officer
12 more named people on record for Xaira Therapeutics, with roles, board committees and tenure — see the full roster →
Xaira Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $1B | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Xaira Therapeutics
Xcout recorded 36 job postings from Xaira Therapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Xaira Therapeutics's job postings
The weekly hiring trend, the roles and locations behind it — see Xaira Therapeutics's hiring signals →
Investors
Tech stack
Xaira Therapeutics competitors
A few of Xaira Therapeutics's closest competitors — see the full list of competitors and alternatives →
Arda Therapeutics is a TechBio therapeutics company focused on accelerating pathobiology-driven therapeutic development. The company is headquartered in the San Francisco Bay Area.
Convexia is a biotechnology research company headquartered in San Francisco, California, United States. It utilizes an end-to-end AI stack to quickly find and acquire early-stage drugs, replacing traditional manual diligence processes with fast execution.
Aikium is a biotechnology company headquartered in Berkeley, California, that integrates deep learning with ultra-large-scale wet lab experimentation to advance protein therapeutics.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Get Xaira Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Xaira Therapeutics? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Xaira Therapeutics in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access